Skip to content

Categories: zymatic

  • Pharem and AstraZeneca joins forces to find sustainable treatment solutions

    Pharem and AstraZeneca joins forces to find sustainable treatment solutions

    Pharem, a Greentech frontrunner in enzyme-based water treatment solutions, has joined forces with the global biopharmaceutical company AstraZeneca to develop sustainable water treatment solutions. Using Pharem's platform Zymatic, the companies target one or several waste streams from API manufacturing to find new ways of treatment using enzymes.

  • Pharem welcomes Jula Holding as new owner

    Pharem welcomes Jula Holding as new owner

    Pharem welcomes Jula Holding as owner in the ongoing series A financing round. Jula Miljö & Energi, a part of Jula Holding, takes a substantial lead position and aims to close the round in the coming months.

  • Zymatic is an enzyme-based treatment technology for treatment of unwanted organic compounds. The enzymes are selected based on treatment needs and bound to a sand-like material. The solution is flexible, easy to install and to operate.

    Pharem receives funding from NEFCO

    Pharem have successfully increased their portfolio of customer related projects, both in the Nordic countries but also internationally. To accelerate these projects Pharem have been granted financing from Nefco.

  • Pharem selected as Semi-Finalist in the QBE AcceliCity Resilience Challange 2021

    Pharem selected as semi-finalist for AcceliCITY 2021

    Of the more than 500 companies from 44 countries that applied to be a part of the AcceliCITY program, Pharem was one of the 50 selected companies that stood out as an exceptional contender. The applicants represent 24 different verticals such as, Internet of Things, AI/Machine Learning, Mobility/Transportation, Urban Agriculture, Smart Health, Smart Water, Security, Environment, to name a few.

  • Pharem and Lonza Solutions initiate treatment project

    Lonza Solutions orders Zymatic project from Pharem

    Lonza Solutions and Pharem Biotech have started a new water treatment project together. Using Zymatic, Pharem's enzyme treatment technology, the treatment step will be tailored to target and treat various organic compounds in one or more selected process streams.

  • Pharem brands the PFS technology to Zymatic and presents a flexible water treatment technology to the market.

    Pharem launches the Zymatic brand after completing the Horizon EU 2020 project

    The Horizon 2020 project (called PFS), which represented Pharem's wastewater treatment technology, has been completed with all important objectives achieved. The project demonstrated the capacity of the enzyme treatment technology under operating conditions at wastewater treatment plants (WWTPs) as well as its ability to remove a wide range of pharmaceutical residues found in effluent wastewater.